Ald patent opposition analysis

The comprehensive analysis of Ald opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Ald

Patent NumberTitleApplicantOpposition DateOpposition Company
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 16, 2026EGIS
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALSJun 10, 2026EGIS
Drug Delivery DeviceAMGENJun 3, 2026MAIWALD
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersREGENERON PHARMACEUTICALSJun 2, 2026NEUEFEIND
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 1, 2026SANDOZ
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 1, 2026MAIWALD
Expansion Anchor And Method For Expanding The Expansion AnchorFISCHERWERKEMay 28, 2026HILTI
Polypropylene-Based Compositions With Transparency And Elongational PropertiesTOTALENERGIES ONETECHMay 20, 2026BOREALIS
A Combination Comprising Two Propylene-Based Polymers And Compositions Comprising The SameEXXONMOBIL CHEMICAL PATENTSMay 13, 2026BOREALIS
Ophthalmic Composition Based On Hyaluronic Acid To Protect From Damages Caused By Environmental PollutionCOLOMBOMay 12, 2026MAIWALD